Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
|
FSH action
|
stimulate estrogen secretion
|
|
|
FSH use
|
Ovulation induction, spermatogenesis induction
|
|
|
hCG use
|
Induce ovulation & pregnancy in anovulatory, infertile females, tx of hypogonadotropic hypogonadism, prepubertal cryptorchidism
|
|
|
Tx of hypogonadotropic hypogonadism
|
hCG
|
|
|
Functional infertility tx
|
hCG
|
|
|
Ovarian hyperstimulation syndrome
|
hCG toxicity: ovarian enlargement, ascites, hydrothorax, hypovolemia sometimes resulting in shock
|
|
|
Leuprolide
|
GnRH analog
|
|
|
Continuous Leuprolide
|
FSH & LH suppression
|
|
|
Sx of continuous leuprolide
|
Menopausal sx: hot flushes, sweats, HAs
|
|
|
Ganirelix
|
Controlled ovarian hyperstimulation procedures
|
|
|
Controlled ovarian hyperstimulation procedures
|
Ganirelix & cetrorelix
|
|
|
Cetrorelix
|
Controlle ovarian hyperstimulation procedures
|
|
|
Abarelix
|
tx of advanced prostate cancer
|
|
|
Tx of advanced prostate cancer
|
Abarelix & degarelix
|
|
|
Degarelix
|
Tx of advanced prostate cancer
|
|
|
Major secretory product of the ovary
|
Estradiol
|
|
|
Most common estrogen used in combo OCPs
|
Ethinyl estradiol
|
|
|
Ethinyl estradiol
|
Most common estrogen used in combo OCPs
|
|
|
Tx of primary hypogonadism
|
Estrogen at 11-13y; add progestin after first uterine bleeding
|
|
|
Suppress ovulation
|
Estrogens & progestins
|
|
|
Suppress ovarian function
|
Estrogens & progestins
|
|
|
Major cause of postmenopausal uterine bleeding (drug)
|
Estrogen
|
|
|
Decrease endometrial carcinoma risk
|
Add progestin with estrogen
|
|
|
Medroxyprogesterone acetate admin
|
IM or SubQ q3mo
|
|
|
Medroxyprogesterone acetate properties
|
Androgenic & antiestrogenic
|
|
|
Desogestrel properties
|
all negative
|
|
|
Norethindrone
|
Slight estrogenic; androgenic, antiestrogenic, anabolic
|
|
|
Levonorgestrel
|
Androgenic, antiestrogenic, anabolic
|
|
|
Ortho Evra
|
Transdermal patch of ethinyl estradiol & norelgestromin
|
|
|
Fertility after medroxyprogesterone d/c
|
delayed for 6-12mo
|
|
|
OCP combo effects
|
inhibition of ovulation; changes in cervical mucus, uterine endometrium & in motility & secretion in the uterine tubes
|
|
|
Depression of ovarian function
|
Chronic use of combo OCPs
|
|
|
Cervical hypertrophy & polyp formation (drug)
|
Chronic OCP use
|
|
|
Breast enlargement & suppression of lactation (drug)
|
estrogen
|
|
|
Fibroid tumor tx
|
Smallest amount of estrogen & most androgenic progestins
|
|
|
Levonorgestrel use
|
morning after contraception
|
|
|
Levonorgestrel MOA
|
progesterone receptor agonist
|
|
|
Postcoital contraception
|
Levonorgestrel & Ulipristal acetate
|
|
|
Does not reverse a pregnancy that has already occurred
|
Levonorgestrel
|
|
|
Interfere with pregnancy
|
Ulipristal acetate (prescription), Mifepristone
|
|
|
Mifepristone MOA
|
progesterone receptor antagonist
|
|
|
Mifepristone use
|
terminate early pregnancy
|
